Treatment of patients with recurrent hepatitis C after liver transplantation with pegylated interferon and ribavirin.

被引：0
|
作者：
Samuel, D [1 ]
机构：
[1] Hop Paul Brousse, Villejuif, France
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
767
引用
收藏
页码：531A / 531A
页数：1
相关论文
共 50 条
  • [31] The Effect and Safety of the Treatment of Recurrent Hepatitis C Infection After Orthotopic Liver Transplantation With Pegylated Interferon α2b and Ribavirin
    Perrakis, A.
    Yedibela, S.
    Schuhmann, S.
    Croner, R.
    Schellerer, V.
    Demir, R.
    Hohenberger, W.
    Mueller, V.
    [J]. TRANSPLANTATION PROCEEDINGS, 2011, 43 (10) : 3824 - 3828
  • [32] Nonresponders of interferon/ribavirin treatment for recurrent hepatitis C following liver transplantation
    Smallwood, GA
    Davis, L
    Connor, K
    Martinez, E
    Stieber, AC
    Heffron, TG
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (04) : 1476 - 1477
  • [33] Pilot study of pegylated interferon alfa-2b and ribavirin for recurrent hepatitis C after liver transplantation
    Mukherjee, S
    Rogge, J
    Weaver, L
    Schafer, DF
    [J]. TRANSPLANTATION PROCEEDINGS, 2003, 35 (08) : 3042 - 3044
  • [34] Two patients treated with pegylated interferon/ribavirin/telaprevir triple therapy for recurrent hepatitis C after living donor liver transplantation
    Kawaoka, Tomokazu
    Takahashi, Shoichi
    Tatsukawa, Yumiko
    Hiramatsu, Akira
    Hiraga, Nobuhiko
    Miki, Daiki
    Tsuge, Masataka
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Ochi, Hidenori
    Ishiyama, Kouhei
    Ide, Kentaro
    Tashiro, Hirotaka
    Ohdan, Hideki
    Chayama, Kazuaki
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (12) : 1259 - 1264
  • [35] Pegylated interferon plus ribavirin in HIV-infected patients with recurrent hepatitis C after liver transplantation: A prospective cohort study
    Castells, Lluis
    Rimola, Antoni
    Manzardo, Christian
    Valdivieso, Andres
    Luis Montero, Jose
    Barcena, Rafael
    Abradelo, Manuel
    Xiol, Xavier
    Aguilera, Victoria
    Salcedo, Magdalena
    Rodriguez, Manuel
    Bernal, Carmen
    Suarez, Francisco
    Antela, Antonio
    Olivares, Sergio
    del Campo, Santos
    Laguno, Montserrat
    Fernandez, Jose R.
    de la Rosa, Gloria
    Agueero, Fernando
    Perez, Inaki
    Gonzalez-Garcia, Juan
    Esteban-Mur, Juan I.
    Miro, Jose M.
    [J]. JOURNAL OF HEPATOLOGY, 2015, 62 (01) : 92 - 100
  • [36] IMPACT OF PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT ON GRAFT SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH RECURRENT HEPATITIS C INFECTION
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Weisner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    [J]. LIVER TRANSPLANTATION, 2008, 14 (07) : S183 - S183
  • [37] Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Wiesner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (11) : 2426 - 2433
  • [38] Treatment of Recurrent Hepatitis C in Liver Transplant Recipients With Extended Duration of Pegylated Interferon and Ribavirin
    Arrigo, Richard
    Samanta, Arun
    Griffith, Shanthini
    Parekh, Ravish M.
    Korogodsky, Maria
    Rao, Kiran V.
    Fisher, Adrian
    Wilson, Dorian
    Klein, Kenneth M.
    Koneru, Baburao
    [J]. GASTROENTEROLOGY, 2011, 140 (05) : S459 - S459
  • [39] Treatment of recurrent hepatitis C after liver transplantation with Interferon alfa 2b and Ribavirin
    Zamboni, F
    Franchello, A
    Lavezzo, B
    Strignano, P
    Schellino, M
    Rizzetto, M
    Salizzoni, M
    [J]. TRANSPLANTATION, 2000, 69 (08) : S265 - S265
  • [40] Ribavirin/interferon-alfa sequential treatment of recurrent hepatitis C after liver transplantation.
    Giostra, E
    Kullak-Ublick, G
    Keller, W
    Fried, R
    Kraehenbuhl, S
    Vanlemmens, C
    Egger, HP
    Clavien, P
    Mentha, G
    Morel, P
    Hadengue, A
    Negro, F
    [J]. HEPATOLOGY, 2001, 34 (04) : 641A - 641A
12345